Skip to main content
CG Invites Co., Ltd. logo

CG Invites Co., Ltd. — Investor Relations & Filings

Ticker · 083790 ISIN · KR7083790006 KO Manufacturing
Open in API
Filings indexed 450 across all filing types
Latest filing 2023-06-12 Major Shareholding Noti…
Country KR South Korea
Listing KO 083790

About CG Invites Co., Ltd.

https://cginvites.com/en

CG Invites Co., Ltd. is a biopharmaceutical company specializing in digital genomics and personalized medicine. The company's activities are focused on four main areas: genomics, personalized cancer vaccines, digital therapeutics, and the development of chemical and biological drugs. It utilizes Whole Genome Sequencing to support precision medicine initiatives and develops mRNA-based personalized cancer vaccines. The company also creates software-based medical interventions, known as digital therapeutics. Its drug development pipeline includes therapeutics for oncology and inflammatory diseases, such as Acelex for osteoarthritis, Ivaltinostat for pancreatic cancer, and Camrelizumab for immuno-oncology. The company's research approach is based on structural chemoproteomics and the integration of genomic data to develop targeted treatments.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service in South Korea. This type of filing is used to disclose changes in share ownership by major shareholders or insiders, which corresponds to the 'Major Shareholding Notification' category (MRQ) in the provided taxonomy.
2023-06-12 Korean
기타경영사항(자율공시)(특허권 취득)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from CrystalGenomics regarding the acquisition of a patent in the United States. It is titled 'Other Management Matters (Voluntary Disclosure)' and provides specific details about the patent, its application, and its strategic use. Since it does not fit into specific categories like financial reports, dividends, or director dealings, and is a standard regulatory disclosure of a corporate event, it is classified as a Regulatory Filing (RNS).
2023-06-08 Korean
기타시장안내(최대주주의의무보유관련)
Major Shareholding Notification Classification · 100% confidence The document is a regulatory announcement from the Korea Exchange regarding CrystalGenomics Inc. It details the compliance status of the company's largest shareholder with mandatory share holding requirements (lock-up periods) following a change in control. Since this is a regulatory notice regarding market compliance and shareholding obligations rather than a financial report, a dividend announcement, or a director's personal trade, it falls under the general regulatory filing category.
2023-06-08 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (DART system) used when an entity or individual crosses a significant ownership threshold (typically 5%) in a listed company. This document details the shareholding changes, the purpose of holding (management influence), and the relationship between the reporting entity and the issuer. This falls under the 'Major Shareholding Notification' category.
2023-06-05 Korean
증권발행결과(자율공시)(제3자배정 유상증자-보통주 및 상환전환우선주)
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '증권 발행결과' (Securities Issuance Result) regarding a third-party capital increase (유상증자). It details the issuance of new common shares and redeemable convertible preferred shares, including the number of shares, total amount, and payment date. This falls under the category of share issuance and capital changes.
2023-06-02 Korean
증권발행결과(자율공시)(제3자배정 유상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a third-party capital increase (share issuance) by CrystalGenomics. It details the number of shares issued, the total amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2023-06-02 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.